LeMaitre Vascular
LMAT
182 hedge funds and large institutions have $845M invested in LeMaitre Vascular in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 64 increasing their positions, 66 reducing their positions, and 23 closing their positions.
0.73% less ownership
Funds ownership: 87.27% → 86.54% (-0.73%)
3% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 66
4% less funds holding
Funds holding: 189 → 182 (-7)
13% less capital invested
Capital invested by funds: $971M → $845M (-$126M)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
Top Sellers
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$9.07M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$2.56M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.17M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$1.56M |
| 5 |
Goldman Sachs
New York
|
-$1.18M |
LMAT Hedge Fund Activity: Q4 2022 in Review
182 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2022, worth a combined $845M — down 13% from $971M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of LMAT and 18 opened new positions — a net loss of 5 holders — while 66 trimmed existing stakes and 64 added.
The largest buyer was Copeland Capital Management, adding an estimated $2.52M. The largest seller was VOYA Investment Management, cutting an estimated $9.07M.
- 182 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2022, down from 189 in Q3 2022.
- Funds reported $845M of LeMaitre Vascular stock for Q4 2022, down 13% quarter-over-quarter.
- 18 funds opened new LeMaitre Vascular positions in Q4 2022 and 23 closed out, a net change of -5 holders.
- The largest LeMaitre Vascular buyer in Q4 2022 was Copeland Capital Management, an estimated $2.52M added.
- The largest LeMaitre Vascular seller in Q4 2022 was VOYA Investment Management, an estimated $9.07M sold.
Based on aggregated 13F filings for Q4 2022.